Effect of Soluplus® on γ-cyclodextrin solubilization of irbesartan and candesartan and their nanoaggregates formation
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Soe, Hay Man Saung HninSripetch, Suppakan
Loftsson, Thorsteinn
Stefánsson, Einar
Jansook, Phatsawee
Issue Date
2021-12-20
Metadata
Show full item recordCitation
1. Soe H, Sripetch S, Loftsson T, Stefansson E, Jansook P. Effect of Soluplus(R) on gamma-cyclodextrin solubilization of irbesartan and candesartan and their nanoaggregates formation. Pharm Dev Technol.doi:10.1080/10837450.2021.2017968.Abstract
The poor aqueous solubility of irbesartan (IRB) and candesartan cilexetil (CAC) may hamper their bioavailability when orally or topically administered. Among several attempts, the promising nanoaggregate formation by gamma-cyclodextrin (gamma CD) complexation of drugs in aqueous solution with or without water-soluble polymers was investigated. According to phase solubility studies, Soluplus (R) showed the highest complexation efficiency (CE) of drug/gamma CD complexes among the polymers tested. The aqueous solubility of IRB and CAC was markedly increased as a function of Soluplus(R) concentrations. The binary drug/gamma CD and ternary drug/gamma CD/Soluplus(R) complex formations were supported and confirmed by solid-state characterizations, including differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform infrared (FT-IR) spectroscopy. The true inclusion mode was also proved by proton nuclear magnetic resonance (H-1-NMR) spectroscopy. The nanoaggregate size and morphology of binary and ternary systems were observed using dynamic light scattering (DLS), and transmission electron microscopy (TEM) techniques. The size of these nanocarriers depends on the concentration of Soluplus(R). The use of Soluplus(R) could significantly enhance drug solubility and stabilize complex nanoaggregates, which could be a prospective platform for drug delivery systems.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://www.tandfonline.com/doi/full/10.1080/10837450.2021.2017968ae974a485f413a2113503eed53cd6c53
10.1080/10837450.2021.2017968
Scopus Count
Collections